cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Hh L Acquisition Co Class A
1 own
2 watching
Current Price
$10.44
$-0.01
(-0.1%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
540.27M
52-Week High
52-Week High
10.68
52-Week Low
52-Week Low
9.8
Average Volume
Average Volume
0M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization540.27M
icon52-Week High10.68
icon52-Week Low9.8
iconAverage Volume0M
iconDividend Yield--
iconP/E Ratio--
What does the Hh L Acquisition Co Class A do?
HH&L Acquisition Co. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on healthcare or healthcare-related companies in Asian markets. The company was incorporated in 2020 and is based in Central, Hong Kong.
Read More
How much money does Hh L Acquisition Co Class A make?
News & Events about Hh L Acquisition Co Class A.
Globe Newswire
1month ago
Abstracts demonstrating XNA technologys improvements to assay sensitivity across different technology platforms and support for use in companion diagnostics (CDx) assay developmentAdditional abstracts to further support XNA technologys potential for use in minimal residual disease (MRD) monitoring ...
Globe Newswire
4 months ago
PLEASANTON, Calif., Jan. 12, 2023 (GLOBE NEWSWIRE) -- DiaCarta, Ltd. (DiaCarta), a precision molecular diagnostics company, today announced thatthe U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for its QuantiVirusTM MPXV test, which is a PCR test for the ...
Globe Newswire
5 months ago
DiaCarta Starts to Receive Samples for Oncuria Bladder Cancer Test at its CLIA Lab PLEASANTON, Calif. and LOS ANGELES, Jan. 05, 2023 (GLOBE NEWSWIRE) -- DiaCarta, Ltd. (DiaCarta), a precision molecular diagnostics company, and Nonagen Bioscience Corporation (Nonagen), a cancer diagnostics company, ...
Business Wire
7 months ago
DiaCarta, Ltd. (DiaCarta or the Company), a precision molecular diagnostics company and developer of novel oncology and infectious disease tests, and HH&L Acquisition Co. (NYSE: HHLA.U, HHLA, HHLA WS) (HH&L), a publicly traded special purpose acquisition company (SPAC), today...
Zolmax
1 year ago
Qube Research & Technologies Ltd lifted its stake in HH&L Acquisition Co. (NYSE:HHLA Get Rating) by 805.8% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 234,459 shares of the companys stock after buying an additional 208,574...
Frequently Asked Questions
Frequently Asked Questions
What is Hh L Acquisition Co Class A share price today?
plus_minus_icon
Can Indians buy Hh L Acquisition Co Class A shares?
plus_minus_icon
How can I buy Hh L Acquisition Co Class A shares from India?
plus_minus_icon
Can Fractional shares of Hh L Acquisition Co Class A be purchased?
plus_minus_icon
What are the documents required to start investing in Hh L Acquisition Co Class A stocks?
plus_minus_icon
What is today’s traded volume of Hh L Acquisition Co Class A?
plus_minus_icon
What is today’s market capitalisation of Hh L Acquisition Co Class A?
plus_minus_icon
What is the 52-Week High and Low Range of Hh L Acquisition Co Class A?
plus_minus_icon
What percentage is Hh L Acquisition Co Class A down from its 52-Week High?
plus_minus_icon
What percentage is Hh L Acquisition Co Class A up from its 52-Week Low?
plus_minus_icon
Current Price
$10.44
$-0.01
(-0.1%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00